Actelion To Lose $80M After Arbitration Ruling
Europe's largest biotechnology company, Actelion Ltd., announced Tuesday that it will lose $80 million in operating profits after a California arbitration panel ordered a subsidiary to pay damages to Japan's Asahi...To view the full article, register now.
Already a subscriber? Click here to view full article